Impact of Pulse Oximetry on Hospital Referral Acceptance in Children Under 5 With Severe Pneumonia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03588377 |
Recruitment Status :
Completed
First Posted : July 17, 2018
Last Update Posted : March 31, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Severe Pneumonia Hypoxemia | Device: Pulse Oximetry | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 543 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Investigator) |
Primary Purpose: | Diagnostic |
Official Title: | Impact of Pulse Oximetry on Hospital Referral Acceptance in Children Under 5 With Severe Pneumonia in District Jamshoro - A Cluster Randomized Trial - (GAPPD Scale up Project) |
Actual Study Start Date : | August 1, 2019 |
Actual Primary Completion Date : | December 31, 2020 |
Actual Study Completion Date : | December 31, 2020 |
Arm | Intervention/treatment |
---|---|
Active Comparator: Intervention Cluster
Signs and symptoms of severe pneumonia Pulse Oximetry
|
Device: Pulse Oximetry
Intervention clusters: On LHW's regular visits to households of their catchment area, they will daily screen for severe pneumonia and check oxygen level in blood using a pulse oximeter in all under <5 children with symptoms of cough or difficulty breathing Case definition:
|
No Intervention: Non-Intervention Cluster
Signs and symptoms of severe pneumonia
|
- Hospital Referral Acceptance [ Time Frame: Day 3 to 7 ]Number of children accepting hospital referral out of total severe pneumonia identified
- Predictors of hospital referral acceptance [ Time Frame: Day 0-3 ]number of children having the predictors (severe signs and symptoms, low distance from referral facility and high WAMI score)
- Comparison of clinical outcomes of children 0-59 months who accepted referral to those who refused admission and were treated at home [ Time Frame: Day 3 to Day 7 ]Treatment failure (no improvement in signs and symptoms of severe pneumonia at day 3 of identification), Deaths in above, Hypoxemia.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 0 Months to 59 Months (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Children of 0-59 months age
- Signs of severe pneumonia (clinical signs only in control clusters, clinical signs and/or hypoxemia in intervention clusters)
- Written informed consent by legal guardian
Exclusion Criteria:
1. Residents of out of catchment areas

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03588377
Pakistan | |
Jāmshoro Office - AKU | |
Jāmshoro, Sindh, Pakistan, 76000 |
Principal Investigator: | Fatima Mir, FCPS | Aga Khan University |
Responsible Party: | Dr Fatime Mir, Associate Professor, Aga Khan University |
ClinicalTrials.gov Identifier: | NCT03588377 |
Other Study ID Numbers: |
4722-Ped-ERC-17 |
First Posted: | July 17, 2018 Key Record Dates |
Last Update Posted: | March 31, 2022 |
Last Verified: | March 2022 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Pneumonia Hypoxia Respiratory Tract Infections Infections |
Lung Diseases Respiratory Tract Diseases Signs and Symptoms, Respiratory |